Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313646909> ?p ?o ?g. }
- W4313646909 endingPage "237" @default.
- W4313646909 startingPage "237" @default.
- W4313646909 abstract "Post-therapeutic relapse, poor survival rates and increasing incidence justify the search for novel therapeutic targets and strategies in cutaneous malignant melanoma (CMM). Within this context, a potential oncogenic role for TrkA in CMM is suggested by reports of NTRK1 amplification, enhanced TrkA expression and intracellular TrkA activation associated with poor prognosis. TrkA, however, exhibits tumour-suppressing properties in melanoma cell lines and has recently been reported not to be associated with CMM progression. To better understand these contradictions, we present the first analysis of potential oncogenic alternative TrkA mRNA splicing, associated with TrkA immunoreactivity, in CMMs, and compare the behaviour of fully spliced TrkA and the alternative TrkAIII splice variant in BRAF(V600E)-mutated A375 melanoma cells. Alternative TrkA splicing in CMMs was associated with unfolded protein response (UPR) activation. Of the several alternative TrkA mRNA splice variants detected, TrkAIII was the only variant with an open reading frame and, therefore, oncogenic potential. TrkAIII expression was more frequent in metastatic CMMs, predominated over fully spliced TrkA mRNA expression in ≈50% and was invariably linked to intracellular phosphorylated TrkA immunoreactivity. Phosphorylated TrkA species resembling TrkAIII were also detected in metastatic CMM extracts. In A375 cells, reductive stress induced UPR activation and promoted TrkAIII expression and, in transient transfectants, promoted TrkAIII and Akt phosphorylation, enhancing resistance to reductive stress-induced death, which was prevented by lestaurtinib and entrectinib. In contrast, fully spliced TrkA was dysfunctional in A375 cells. The data identify fully spliced TrkA dysfunction as a novel mechanism for reducing melanoma suppression, support a causal relationship between reductive stress, UPR activation, alternative TrkAIII splicing and TrkAIII activation and characterise a targetable oncogenic pro-survival role for TrkAIII in CMM." @default.
- W4313646909 created "2023-01-07" @default.
- W4313646909 creator A5001849442 @default.
- W4313646909 creator A5003045874 @default.
- W4313646909 creator A5010312319 @default.
- W4313646909 creator A5021496401 @default.
- W4313646909 creator A5022153428 @default.
- W4313646909 creator A5028208326 @default.
- W4313646909 creator A5037511312 @default.
- W4313646909 creator A5050044785 @default.
- W4313646909 creator A5059610917 @default.
- W4313646909 creator A5059841248 @default.
- W4313646909 creator A5060226975 @default.
- W4313646909 creator A5060835144 @default.
- W4313646909 creator A5061577035 @default.
- W4313646909 creator A5066364596 @default.
- W4313646909 creator A5072580236 @default.
- W4313646909 date "2023-01-05" @default.
- W4313646909 modified "2023-09-26" @default.
- W4313646909 title "The Alternative TrkAIII Splice Variant, a Targetable Oncogenic Participant in Human Cutaneous Malignant Melanoma" @default.
- W4313646909 cites W1541024168 @default.
- W4313646909 cites W1854332140 @default.
- W4313646909 cites W1982687515 @default.
- W4313646909 cites W2020145209 @default.
- W4313646909 cites W2026588006 @default.
- W4313646909 cites W2031591517 @default.
- W4313646909 cites W2035013183 @default.
- W4313646909 cites W2035897513 @default.
- W4313646909 cites W2038633902 @default.
- W4313646909 cites W2042181300 @default.
- W4313646909 cites W2043001906 @default.
- W4313646909 cites W2052005627 @default.
- W4313646909 cites W2055343221 @default.
- W4313646909 cites W2060769500 @default.
- W4313646909 cites W2087618734 @default.
- W4313646909 cites W2103116338 @default.
- W4313646909 cites W2123785598 @default.
- W4313646909 cites W2131387907 @default.
- W4313646909 cites W2136156458 @default.
- W4313646909 cites W2155184582 @default.
- W4313646909 cites W2167755204 @default.
- W4313646909 cites W2172114433 @default.
- W4313646909 cites W2174095318 @default.
- W4313646909 cites W2278675766 @default.
- W4313646909 cites W2279591321 @default.
- W4313646909 cites W2287835706 @default.
- W4313646909 cites W2557889809 @default.
- W4313646909 cites W2759551874 @default.
- W4313646909 cites W2768243755 @default.
- W4313646909 cites W2771634366 @default.
- W4313646909 cites W2780009084 @default.
- W4313646909 cites W2795877840 @default.
- W4313646909 cites W2809131968 @default.
- W4313646909 cites W2886540861 @default.
- W4313646909 cites W2900024613 @default.
- W4313646909 cites W2943939475 @default.
- W4313646909 cites W2949185749 @default.
- W4313646909 cites W2965873243 @default.
- W4313646909 cites W2981564682 @default.
- W4313646909 cites W3000052733 @default.
- W4313646909 cites W3006997302 @default.
- W4313646909 cites W3034600147 @default.
- W4313646909 cites W3036078303 @default.
- W4313646909 cites W3041818318 @default.
- W4313646909 cites W3045974148 @default.
- W4313646909 cites W3095878484 @default.
- W4313646909 cites W3119946474 @default.
- W4313646909 cites W3125734520 @default.
- W4313646909 cites W3142571537 @default.
- W4313646909 cites W3155619633 @default.
- W4313646909 cites W3155807164 @default.
- W4313646909 cites W3161691797 @default.
- W4313646909 cites W4205264902 @default.
- W4313646909 cites W4223447259 @default.
- W4313646909 cites W4296354513 @default.
- W4313646909 doi "https://doi.org/10.3390/cells12020237" @default.
- W4313646909 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36672171" @default.
- W4313646909 hasPublicationYear "2023" @default.
- W4313646909 type Work @default.
- W4313646909 citedByCount "0" @default.
- W4313646909 crossrefType "journal-article" @default.
- W4313646909 hasAuthorship W4313646909A5001849442 @default.
- W4313646909 hasAuthorship W4313646909A5003045874 @default.
- W4313646909 hasAuthorship W4313646909A5010312319 @default.
- W4313646909 hasAuthorship W4313646909A5021496401 @default.
- W4313646909 hasAuthorship W4313646909A5022153428 @default.
- W4313646909 hasAuthorship W4313646909A5028208326 @default.
- W4313646909 hasAuthorship W4313646909A5037511312 @default.
- W4313646909 hasAuthorship W4313646909A5050044785 @default.
- W4313646909 hasAuthorship W4313646909A5059610917 @default.
- W4313646909 hasAuthorship W4313646909A5059841248 @default.
- W4313646909 hasAuthorship W4313646909A5060226975 @default.
- W4313646909 hasAuthorship W4313646909A5060835144 @default.
- W4313646909 hasAuthorship W4313646909A5061577035 @default.
- W4313646909 hasAuthorship W4313646909A5066364596 @default.
- W4313646909 hasAuthorship W4313646909A5072580236 @default.
- W4313646909 hasBestOaLocation W43136469091 @default.
- W4313646909 hasConcept C151730666 @default.